rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1-2
|
pubmed:dateCreated |
2011-1-3
|
pubmed:abstractText |
The purpose of this study was to elucidate the treatment efficacy and safety of gemcitabine monotherapy, and to identify prognostic factors in patients with advanced biliary tract cancer receiving this therapy.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1423-0232
|
pubmed:author |
pubmed-author:FuruseJunjiJ,
pubmed-author:HagiharaAtsushiA,
pubmed-author:IkedaMasafumiM,
pubmed-author:KojimaYasushiY,
pubmed-author:KondoShunsukeS,
pubmed-author:MitsunagaShuichiS,
pubmed-author:MorizaneChigusaC,
pubmed-author:NakachiKoheiK,
pubmed-author:OkusakaTakujiT,
pubmed-author:ShimizuSatoshiS,
pubmed-author:SuzukiEiichiroE,
pubmed-author:UenoHidekiH
|
pubmed:copyrightInfo |
Copyright © 2010 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
79
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
39-45
|
pubmed:meshHeading |
pubmed-meshheading:21063134-Adult,
pubmed-meshheading:21063134-Aged,
pubmed-meshheading:21063134-Aged, 80 and over,
pubmed-meshheading:21063134-Analysis of Variance,
pubmed-meshheading:21063134-Antimetabolites, Antineoplastic,
pubmed-meshheading:21063134-Biliary Tract Neoplasms,
pubmed-meshheading:21063134-C-Reactive Protein,
pubmed-meshheading:21063134-Carcinoembryonic Antigen,
pubmed-meshheading:21063134-Deoxycytidine,
pubmed-meshheading:21063134-Disease-Free Survival,
pubmed-meshheading:21063134-Female,
pubmed-meshheading:21063134-Humans,
pubmed-meshheading:21063134-Male,
pubmed-meshheading:21063134-Middle Aged,
pubmed-meshheading:21063134-Neoplasm Staging,
pubmed-meshheading:21063134-Predictive Value of Tests,
pubmed-meshheading:21063134-Prognosis,
pubmed-meshheading:21063134-Retrospective Studies,
pubmed-meshheading:21063134-Serum Albumin,
pubmed-meshheading:21063134-Treatment Outcome,
pubmed-meshheading:21063134-Tumor Markers, Biological
|
pubmed:year |
2010
|
pubmed:articleTitle |
Treatment efficacy/safety and prognostic factors in patients with advanced biliary tract cancer receiving gemcitabine monotherapy: an analysis of 100 cases.
|
pubmed:affiliation |
Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Chiba, Japan. eisuzuki@ks.kyorin-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|